We’re Working Toward a Healthier Future
At Inhibikase Therapeutics, we’re at the forefront of improving treatment outcomes in kinase-sensitive neurodegenerative diseases.
We’re leveraging our Re-engineering Approach with Metabolism Preserved (RAMP™) drug innovation engine to generate a family of novel small-molecule kinase inhibitors with improved potency and retained safety profiles for the treatment of neurodegenerative diseases.
We actively seek out talented individuals who share our commitment to helping patients with infectious or neurodegenerative diseases that have little to no treatment options. Apply today!